Literature DB >> 2229575

Grading liposarcomas with PET using [18F]FDG.

L P Adler1, H F Blair, R P Williams, M N Pathria, J T Makley, M J Joyce, N al-Kaisi, F Miraldi.   

Abstract

Five patients with liposarcomas of the thigh were studied using positron emission tomography (PET) with [18F]2-deoxy-2-fluoroglucose (FDG). There were three low-grade tumors (all National Cancer Institute Grade 1 myxoid liposarcomas) and two high-grade tumors (both pleomorphic liposarcomas, Grades 2 and 3). The low-grade liposarcomas were easily identified with an average dose uptake ratio (DUR) of 1.38 +/- 0.045 (mean +/- SD). The high-grade lesions were more avid for FDG with a mean DUR of 2.45 +/- 0.24. There was a significant difference (p = 0.004) in the DUR for the two groups and the histological grade of malignancy was highly correlated with the DUR for FDG (Rho = 0.89). These findings suggest that FDG-PET may be useful for distinguishing between low-grade and high-grade liposarcomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229575     DOI: 10.1097/00004728-199011000-00017

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

Review 1.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 2.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

3.  The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.

Authors:  N Y Tse; C K Hoh; R A Hawkins; M J Zinner; M Dahlbom; Y Choi; J Maddahi; F C Brunicardi; M E Phelps; J A Glaspy
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

4.  The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma.

Authors:  Hoon Hur; Sung Hoon Kim; Wook Kim; Kyo Young Song; Cho Hyun Park; Hae Myung Jeon
Journal:  World J Surg Oncol       Date:  2010-10-11       Impact factor: 2.754

5.  Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.

Authors:  J P Crowe; L P Adler; R R Shenk; J Sunshine
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

6.  18FDG PET scanning of benign and malignant musculoskeletal lesions.

Authors:  Frieda Feldman; Ronald van Heertum; Chitra Manos
Journal:  Skeletal Radiol       Date:  2003-03-11       Impact factor: 2.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.